Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Partners With AmoyDx On Companion Diagnostics For Lynparza

Apr 18 2022

• By Joseph Haas

Diagnostic test — AstraZeneca is partnering to develop additional companion diagnostics for Lynparza • Source: Alamy

Related Content

AZ/Merck & Co' s Lynparza Gets US Approval For Prostate Cancer

May 20 2020

FDA Approves Foundation Medicine Liquid Biopsy Test As Companion Diagnostic For Lynparza

Nov 09 2020

Related Companies

AstraZeneca PLC

Merck & Co., Inc.

Roche Holding AG

Foundation Medicine, Inc.

Amoy Diagnostics Co., Ltd.

Amgen, Inc.

Merck KGaA

HUTCHMED (China) Limited

Shanghai HaiHe Pharmaceutical Co., Ltd.

Pfizer Inc.

Pierre Fabre

Additional Topics

Deals Personalized Medicine Business Strategies Commercial Cancer BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window